Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease

Stroke

Volumn 32, Issue 12, 2001, Pages 2817-2820

  Sterzer, Philipp ^a   Meintzschel, Frank ^a   Rösler, Alexander ^a   Lanfermann, Heinrich ^a   Steinmetz, Helmuth ^a   Sitzer, Matthias ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Endothelium; HMG CoA reductase inhibitors; Small vessel disease; Ultrasonography; Vasomotor reactivity

Indexed keywords

ACETAZOLAMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADULT; AGED; ARTICLE; BOLUS INJECTION; BRAIN BLOOD FLOW; BRAIN VASOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STROKE; VASOMOTOR REFLEX;

EID: 0035207933     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs1201.099663     Document Type: Article

References (23)

1. Pravastatin therapy and the risk of stroke
2. Statins and the risk of dementia
3. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterollowering actions
4. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly
5. Reduced vasomotor reactivity in cerebral small vessel disease
6. A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide
7. Magnetic resonance imaging of regional cerebral blood oxygenation changes under acetazolamide in carotid occlusive disease
8. Beneficial effects of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients
9. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
10. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
11. Vascular function in the forearm of hypercholesterolaemic patiens off and on lipid-lowering medication
12. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
13. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month
14. Increased bioavailability of nitric oxide after lipidlowering therapy in hypercholesterolemic patients: A randomized, placebo-controlled, double-blind study
15. Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia
16. 2 reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia
17. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
18. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment
19. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice
20. Effects of acetazolamide on cerebrocortical NADH and blood volume
21. Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography
22. Carbon dioxide and the cerebral circulation
23. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia